Endovia Health Sciences, Inc. (EDVA)
| Market Cap | 1.02M -79.8% |
| Revenue (ttm) | 32,090 -90.9% |
| Net Income | -18.84M |
| EPS | -13.60 |
| Shares Out | 6.41M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 411,144 |
| Open | 0.1623 |
| Previous Close | 0.1610 |
| Day's Range | 0.1515 - 0.1642 |
| 52-Week Range | 0.1515 - 13.4000 |
| Beta | -1.09 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 19, 2026 |
About EDVA
Endovia Health Sciences, Inc. develops a diversified cannabinoid health sciences platform that translates science into regulated therapies and trusted health and wellness products for people and animals in Ireland, United Kingdom, Australia, and Latin America. Its product includes CannEpil a pharmaceutical-grade cannabinoid formulation comprising cannabidiol and tetrahydrocannabinol isolates in an oral liquid solution. Endovia Health Sciences, Inc. formerly known as Splash Beverage Group, Inc. The company is based in Fort Lauderdale, Florida.
Financial Performance
In 2025, Endovia Health Sciences's revenue was $73,066, a decrease of -90.88% compared to the previous year's $801,273. Losses were -$26.07 million, 9.72% more than in 2024.
Financial StatementsNews
Endovia Health Sciences Proxy statement: Proxy filing
Endovia Health Sciences filed a proxy statement on September 23, 2026, providing details for shareholder voting and corporate governance matters.
Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil® Development Amid Growing Federal Support for Botanical Drug Pathways
Endovia financing comes as FDA and Congress increase focus on advancing and incentivizing regulated development of botanical and plant-derived medicines
Endovia Health Sciences Proxy statement: Proxy filing
Endovia Health Sciences filed a proxy statement on September 18, 2026, providing details for shareholder voting and corporate governance matters.
Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil® FDA Submission and Expands Development Pipeline
Endovia Health Sciences believes the federal government's affirmative support for Schedule III represents a significant evolution in U.S. cannabinoid poli
Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil® Veterinary Development Program
FORT LAUDERDALE, Fla., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Endovia Health Sciences, Inc. (NYSE American: EDVA), formerly Splash Beverage Group, Inc. (NYSE American: SBEV) ("Endovia Health" or the "Compa...
Splash Beverage Group to Become Endovia Health Sciences; New NYSE American Ticker “EDVA” Effective Monday
FORT LAUDERDALE, Fla., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) (the “Company”) today announced that its corporate name will change to Endovia Health Science...
Splash Beverage Reports Second Quarter 2026 Results and Highlights Strategic Transformation Toward Endovia Health Sciences
FORT LAUDERDALE, Fla., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”) today reported financial results for the second quarter ended Jun...
Splash Beverage Group to Rebrand as Endovia Health Sciences
FORT LAUDERDALE, Fla., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) (the "Company") today announced its intention to change its corporate name to Endovia Health ...
Splash Beverage Group Partners with Veteran Cannabinoid Drug-Development Team to Advance CannEpil® Through FDA Veterinary Pathway
Collaboration with Lupvindol Biosciences will initially target companion-animal oncology and chronic pain management Splash retains ownership of resulting data, intellectual property and commercializa...
Splash Beverage Group Expands CannEpil® Platform into Veterinary Therapeutics, Establishing Second FDA-Regulated Pharmaceutical Development Program
Splash expands its exclusive global license for CannEpil® to include veterinary applications, creating a second regulated pharmaceutical development platfo
Splash Beverage Group Announces Significant Balance Sheet Improvement and Board Approval of Reverse Stock Split as Company Continues Strategic Transformation
SPLASH announces significant actions designed to strengthen the Company's financial position and advance its previously announced NYSE compliance plan.
Splash Beverage Group Receives NYSE American Acceptance of Compliance Plan, Establishing Defined Path Toward Continued Listing and Strategic Transformation
FORT LAUDERDALE, Fla., July 09, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) ("Splash," "Splash Beverage" or the "Company") today announced that NYSE American has accepte...
Splash Beverage Group Acquires Exclusive Global Rights to CannEpil®, an Epilepsy Therapy with Established European Patient Access, FDA Engagement and U.S. Development Potential
$SBEV announces licensing agreement with Argent BioPharma for CannEpil®, a proprietary, cannabinoid-based therapeutic for the treatment of epilepsy (DRE)
Splash Beverage Group Invests in Avicanna, a Leading Cannabinoid Biopharmaceutical Platform, Advancing Its Transformation Into Cannabinoid Healthcare
FORT LAUDERDALE, Fla., June 15, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) today announced the completion of a CDN$300,000 strategic investment in Avicanna Inc. (TSX: A...
Splash Beverage Group Provides Corporate Update on NYSE Compliance Process and Strategic Transaction Initiatives
FORT LAUDERDALE, Fla., June 03, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) ("Splash" or the "Company"), today provided a corporate update regarding its NYSE American co...
Splash Beverage Group Announces Leadership Transition and Strategic Evolution Toward High-Growth Wellness & Cannabinoid Markets
FORT LAUDERDALE, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group (NYSE American: SBEV) (“Splash” or the “Company”) today announced the appointment of Brady Cobb as Interim Chief Executive...
Splash Beverage Group Receives NYSE Notice Regarding Shareholders' Equity Requirement; will execute a plan to Regain Compliance
FORT LAUDERDALE, Fla., May 05, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), today announced that on April 29, 2026, it received a notice from...
NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Splash Beverage Group, Inc. (SBEV-WT)
NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants — ticke...
NYSE American to Commence Delisting Proceedings Against Splash Beverage Group, Inc. (SBEV)
NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the two securities e...
Splash Beverage Group Expands Pulpoloco Sangria Distribution With Total Wine & More
FORT LAUDERDALE, FL / ACCESSWIRE / December 12, 2024 / Splash Beverage Group, Inc. (NYSE American:SBEV), an innovator in the beverage industry, proudly announces another 2024 retail expansion win. Tot...
Splash Beverage Group to Host Conference Call to Discuss 2024 Third Quarter Results & State of the Business Update
FORT LAUDERDALE, FL / ACCESSWIRE / November 18, 2024 / Splash Beverage Group, Inc. (NYSE American:SBEV) ("Splash" or the "Company"), a portfolio company of leading beverage brands, announced that it w...
Splash Beverage Group Announces Successful First Tranche of Capital Raise for Strategic Acquisition
FORT LAUDERDALE, FL / ACCESSWIRE / October 16, 2024 / Splash Beverage Group (NYSE American:SBEV) ("Splash" or the "Company"), a portfolio company of leading beverage brands, is excited to announce con...
Splash Beverage Group Announces Its Initial Closing on the First Tranche of Private Placement
FORT LAUDERDALE, FL / ACCESSWIRE / August 22, 2024 / Splash Beverage Group, Inc. (NYSE American:SBEV) ("Splash" or the "Company"), a portfolio company of leading beverage brands, announced that it has...
Splash Beverage Group to Host Conference Call to Discuss 2024 Second Quarter Results & State of the Business Update
2024 Second Quarter Results & State of the Business Update FORT LAUDERDALE, FL / ACCESSWIRE / August 15, 2024 / Splash Beverage Group, Inc. (NYSE American:SBEV) ("Splash" or the "Company"), a portfoli...
Splash Beverage Group Secures Statewide Authorization for SALT Naturally Flavored Tequila in Pennsylvania
FORT LAUDERDALE, FL / ACCESSWIRE / July 18, 2024 / Splash Beverage Group, Inc. (NYSE American:SBEV), a leading beverage company known for acquiring and growing early-stage brands to national and inter...